Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat

Behavioural Brain Research

Volumn 139, Issue 1-2, 2003, Pages 105-113

  Henderson, J M ^a,c   Watson, S ^a   Halliday, G M ^a   Heinemann, T ^b   Gerlach, M ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c University of Sydney   (Australia)

Author keywords

6 Hydroxydopamine; Behavioural analysis; Parkinsonism; Rat; Stereology; Striatal neurochemistry

Indexed keywords

APOMORPHINE; DOPAMINE; NEUROTRANSMITTER; OXIDOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; HEAD POSITION; MOTOR DYSFUNCTION; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SUBSTANTIA NIGRA;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; CELL DEATH; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; FUNCTIONAL LATERALITY; MUSCULOSKELETAL EQUILIBRIUM; NEOSTRIATUM; NEURONS; ORIENTATION; OXIDOPAMINE; PARKINSONIAN DISORDERS; PERCEPTUAL DISORDERS; POSTURE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0037450073     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(02)00087-6     Document Type: Article

References (29)

1. Annett L.E., Rogers D.C., Hernandez T.D., Dunnett S.B. Behavioural analysis of unilateral monoamine depletion in the marmoset. Brain. 115:1992;825-856.
2. Annett L.E., Smyly R.E., Henderson J.M., Cummings R.M., Kendall A.L., Dunnett S.B. Behavioural assessment in the unilateral dopamine-depleted marmoset. Emerich D.F., Dean R.L.I., Sanberg P.R. Central nervous system diseases. Innovative animal models from lab to clinic. 2000;171-186 Humana Press, Totowa, NJ.
3. Barnéoud P., Descrombris E., Aubin N., Abrous D.N. Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system. Eur. J. Neurosci. 12:2000;322-336.
4. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Settelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20:1973;415-455.
5. Borlongan C.V., Sanberg P.R. Elevated body swing test: a new behavioural parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J. Neurosci. 15:1995;5372-5378.
6. Caligiuri M.P., Heindel W.C., Lohr J.B. Sensorimotor disinhibition in Parkinson's disease: effects of levodopa. Ann. Neurol. 31:1992;53-58.
7. Dunnett S.B., Bjorklund A. Conditioned turning in rats: dopaminergic involvement in the intitiation of movement rather than the movement itself. Neurosci. Lett. 41:1983;173-178.
8. Ehringer H., Hornykiewicz O. Verteilung von noradrenalin und dopamin (3-Hydro-xytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extra-pyramidalen systems. Wien Klin Wschr. 38:1960;1236-1239.
9. Elsworth J.D., Taylor J.R., Sladek J.R.J., Collier T.J., Redmond D.E.J., Roth R.H. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience. 95:2000;399-408.
10. Fearnley J., Lees A. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 114:1991;2283-2301.
11. Fornaguera J., Carey R.J., Dai H., Huston J.P., Schwarting R.K.W. Differentiation of motor inactivation from movement asymmetry effects in an animal model of hemi-parkinsonism. NeuroReport. 6:1994;173-176.
12. Fornaguera J., Carey R.J., Huston J.P., Schwarting R.K.W. Behavioural asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion. Brain Res. 664:1994;178-188.
13. Gerlach M., Gsell W., Kornhuber J., Jellinger K., Krieger V., Pantucek F., Vock R., Riederer P. A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res. 741:1996;142-152.
14. Gerlach M., Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural Transm. 103:1996;987-1041.
15. Halliday G., McRitchie D., Cartwright H., Pamphlett R., Hely M., Morris J. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J. Clin. Neurosci. 3:1996;52-60.
16. 3H] spiroperidol binding and rotational behaviour in unilaterally 6-hydroxydopamine-lesioned rats. Brain Res. 211:1981;285-292.
17. Henderson J.M., Annett L.E., Ryan L.J., Chiang W., Hidaka S., Torres E.M., Dunnett S.B. Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat. Eur. J. Neurosci. 11:1999;2749-2757.
18. Henderson J.M., Annett L.E., Torres E.M., Dunnett S.B. Behavioural effects of subthalamic lesions in hemiparkinsonian marmosets. Eur. J. Neurosci. 10:1998;689-698.
19. Kirik D., Rosenblad C., Bjorklund A. Characterization of behavioural and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152:1998;259-277.
20. Moore A.E., Cicchetti F., Hennen J., Isacson O. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat. Exp. Neurol. 172:2001;363-376.
21. Paxinos G., Watson C. The rat brain in stereotactic coordinates. fourth ed. 1998;Academic Press, San Diego.
22. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 67:1995;631-647.
23. Schallert T., Hall S. 'Disengage' sensorimotor deficit following apparent recovery from unilateral dopamine depletion. Behav. Brain Res. 30:1988;15-24.
24. Schwarting R.K., Bonatz A.E., Carey R.J., Huston J.P. Relationships between indices of behavioural asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections. Brain Res. 554:1991;46-55.
25. Schwarting R.K.W., Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioural brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50:1996;275-331.
26. Schwarting R.K.W., Huston J.P. Unilateral 6-hydroxydopamine lesions of the meso-striatal dopamine neurons and their physiologica sequelae. Prog. Neurobiol. 49:1996;215-266.
27. Sherman T.G., Moody C.A. Alterations in tyrosine hydroxylase expression following partial lesions of the nigrostriatal bundle. Mol. Brain Res. 29:1995;285-296.
28. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;59-73.
29. Xiao A.Y., Double K., Heinemann T., Rausch W.D., Riederer P., Gerlach M. The industrial chemical Tinuvin 123 does not induce dopaminergic toxicity in C57BI/6 mice. Neurosci. Lett. 278:2000;165-168.